Japan Tissue Engineering Co., Ltd. - ROE
7774.T
Price:
$790
Market Cap:
$32.08B
Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine sector in Japan. The company's activities are organized into three core divisions: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It manufactures and delivers autologous cultured tissues, such as epidermis, cartilage, corneal epithelium, and oral mucosal epithelium, to medical institutions for therapeutic applications. The firm also produces other advanced tissue-engineered medical products. Furthermore, Japan Tissue Engineering is involved in the research and development of three-dimensional human cultured tissue models, which are utilized in the development ...[Read more]
Industry
Biotechnology
IPO Date
2007-12-28
Stock Exchange
JPX
Ticker
7774.T
PE Ratio
[-72.74]
ROE
[-8.40%]
Current Ratio
[6.03]
Dividend Yield
[0%]
Enterprise Value
[28.73B]
Dividend History
The ROE as of September 2026 (TTM) for Japan Tissue Engineering Co., Ltd. (7774.T) is -8.40%
According to Japan Tissue Engineering Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -8.40%. This represents a change of 301.74% compared to the average of -2.09% of the last 4 quarters.
Japan Tissue Engineering Co., Ltd. (7774.T) Historical ROE (quarterly & annually)
How has 7774.T ROE performed in the past?
The mean historical ROE of Japan Tissue Engineering Co., Ltd. over the last ten years is -4.45%. The current -8.40% ROE has changed 88.85% with respect to the historical average. Over the past ten years (40 quarters), 7774.T's ROE was at its highest in in the March 2017 quarter at 5.99%. The ROE was at its lowest in in the June 2018 quarter at -5.64%.
Average
-4.45%
Median
-4.30%
Minimum
-14.43%
Maximum
3.45%
Japan Tissue Engineering Co., Ltd. (7774.T) ROE by Quarter and Year
Discovering the peaks and valleys of Japan Tissue Engineering Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 229.34%
Maximum Annual ROE = 3.45%
Minimum Annual Increase = -286.14%
Minimum Annual ROE = -14.43%
| Year | ROE | Change |
|---|---|---|
| 2026 | -14.43% | 229.34% |
| 2025 | -4.38% | -286.14% |
| 2024 | 2.35% | -119.17% |
| 2023 | -12.28% | 64.48% |
| 2022 | -7.47% | 14.67% |
| 2021 | -6.51% | 73.12% |
| 2020 | -3.76% | -10.61% |
| 2019 | -4.21% | -252.39% |
| 2018 | 2.76% | -19.97% |
| 2017 | 3.45% | -139.08% |
Japan Tissue Engineering Co., Ltd. (7774.T) Average ROE
How has 7774.T ROE performed in the past?
The current ROE of Japan Tissue Engineering Co., Ltd. (7774.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.49%
5-year avg
-7.24%
10-year avg
-4.45%
Japan Tissue Engineering Co., Ltd. (7774.T) ROE vs. Peers
How is 7774.T’s ROE compared to its peers?
Japan Tissue Engineering Co., Ltd.’s ROE is greater than Oncolys BioPharma Inc. (-47.76%), greater than StemRIM (-29.35%), greater than CanBas Co., Ltd. (-60.26%), greater than CellSeed Inc. (-66.94%), greater than ReproCELL Incorporated (-4.94%), less than Ohki Healthcare Holdings Co.,Ltd. (2.25%), less than Astena Holdings Co., Ltd. (8.48%), less than Fuso Pharmaceutical Industries,Ltd. (6.28%), greater than Stella Pharma Corporation (-30.36%), less than RaQualia Pharma Inc. (2.23%),
| Company | ROE | Market cap |
|---|---|---|
| -47.76% | $168.09B | |
| -29.35% | $11.28B | |
| -60.26% | $14.46B | |
| -66.94% | $8.63B | |
| -4.94% | $13.22B | |
| 2.25% | $13.64B | |
| 8.48% | $20.54B | |
| 6.28% | $18.63B | |
| -30.36% | $14.80B | |
| 2.23% | $13.26B |
Build a custom stock screener for Japan Tissue Engineering Co., Ltd. (7774.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Japan Tissue Engineering Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Japan Tissue Engineering Co., Ltd. (7774.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Japan Tissue Engineering Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Japan Tissue Engineering Co., Ltd.'s ROE?
How is the ROE calculated for Japan Tissue Engineering Co., Ltd. (7774.T)?
What is the highest ROE for Japan Tissue Engineering Co., Ltd. (7774.T)?
What is the 3-year average ROE for Japan Tissue Engineering Co., Ltd. (7774.T)?
What is the 5-year average ROE for Japan Tissue Engineering Co., Ltd. (7774.T)?
How does the current ROE for Japan Tissue Engineering Co., Ltd. (7774.T) compare to its historical average?